Deep Track Capital LP 13D and 13G filings for Apogee Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 10:18 am Sale | 2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE | Deep Track Capital LP | 1,000,000 2.220% | -1,323,456 (-56.96%) | Filing |
| 2024-02-14 08:35 am Sale | 2023-12-31 | 13G | Apogee Therapeutics, Inc. APGE | Deep Track Capital LP | 2,323,456 6.250% | -700,000 (-23.15%) | Filing |
| 2023-07-24 4:05 pm Purchase | 2023-07-14 | 13G | Apogee Therapeutics, Inc. APGE | Deep Track Capital LP | 3,023,456 8.870% | 3,023,456 (New Position) | Filing |